Controlled release of a model protein lysozyme from phase sensitive smart polymer systems

Somnath Singh, Jagdish Singh

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The purpose of this study was to investigate the suitability of phase sensitive smart polymer-based protein formulations in order to deliver a model protein, lysozyme, in a conformationally stable and biologically active form at a controlled rate over extended period of time. Four different formulations, using D,L-poly(lactide) (D,L-PLA) and a solvent mixture of different ratios of benzyl benzoate (BB) and benzyl alcohol (BA), were prepared. Conformational stability and biological activity of lysozyme were studied by differential scanning calorimeter and enzyme activity assay, respectively. We found a significant (P

Original languageEnglish
Pages (from-to)189-196
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume271
Issue number1-2
DOIs
StatePublished - Mar 1 2004

Fingerprint

Muramidase
Polymers
Benzyl Alcohol
Enzyme Assays
Proteins
poly(lactide)
benzyl benzoate

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Controlled release of a model protein lysozyme from phase sensitive smart polymer systems. / Singh, Somnath; Singh, Jagdish.

In: International Journal of Pharmaceutics, Vol. 271, No. 1-2, 01.03.2004, p. 189-196.

Research output: Contribution to journalArticle

@article{4d9285d2e2df47af9dd5db100069db87,
title = "Controlled release of a model protein lysozyme from phase sensitive smart polymer systems",
abstract = "The purpose of this study was to investigate the suitability of phase sensitive smart polymer-based protein formulations in order to deliver a model protein, lysozyme, in a conformationally stable and biologically active form at a controlled rate over extended period of time. Four different formulations, using D,L-poly(lactide) (D,L-PLA) and a solvent mixture of different ratios of benzyl benzoate (BB) and benzyl alcohol (BA), were prepared. Conformational stability and biological activity of lysozyme were studied by differential scanning calorimeter and enzyme activity assay, respectively. We found a significant (P",
author = "Somnath Singh and Jagdish Singh",
year = "2004",
month = "3",
day = "1",
doi = "10.1016/j.ijpharm.2003.11.010",
language = "English",
volume = "271",
pages = "189--196",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Controlled release of a model protein lysozyme from phase sensitive smart polymer systems

AU - Singh, Somnath

AU - Singh, Jagdish

PY - 2004/3/1

Y1 - 2004/3/1

N2 - The purpose of this study was to investigate the suitability of phase sensitive smart polymer-based protein formulations in order to deliver a model protein, lysozyme, in a conformationally stable and biologically active form at a controlled rate over extended period of time. Four different formulations, using D,L-poly(lactide) (D,L-PLA) and a solvent mixture of different ratios of benzyl benzoate (BB) and benzyl alcohol (BA), were prepared. Conformational stability and biological activity of lysozyme were studied by differential scanning calorimeter and enzyme activity assay, respectively. We found a significant (P

AB - The purpose of this study was to investigate the suitability of phase sensitive smart polymer-based protein formulations in order to deliver a model protein, lysozyme, in a conformationally stable and biologically active form at a controlled rate over extended period of time. Four different formulations, using D,L-poly(lactide) (D,L-PLA) and a solvent mixture of different ratios of benzyl benzoate (BB) and benzyl alcohol (BA), were prepared. Conformational stability and biological activity of lysozyme were studied by differential scanning calorimeter and enzyme activity assay, respectively. We found a significant (P

UR - http://www.scopus.com/inward/record.url?scp=1142285516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1142285516&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2003.11.010

DO - 10.1016/j.ijpharm.2003.11.010

M3 - Article

VL - 271

SP - 189

EP - 196

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -